| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 76431-210-01 | 76431-210 | HUMAN PRESCRIPTION DRUG | Myalept | metreleptin | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | SUBCUTANEOUS | 20150305 | N/A | BLA | BLA125390 | Amryt Pharmaceuticals Designated Activity Company | METRELEPTIN | 11.3 mg/2.2mL | 1 VIAL, GLASS in 1 CARTON (76431-210-01) / 2.2 mL in 1 VIAL, GLASS |
| 10122-210-02 | 10122-210 | HUMAN PRESCRIPTION DRUG | Myalept | metreleptin | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | SUBCUTANEOUS | 20150305 | N/A | BLA | BLA125390 | Chiesi USA, Inc. | METRELEPTIN | 11.3 mg/2.2mL | 1 VIAL, GLASS in 1 CARTON (10122-210-02) / 2.2 mL in 1 VIAL, GLASS |